glp-1 drugs semaglutide GLP-1s Blockbuster GLP-1 Diabetes and Weight

ZP CON BS Q12026 MOUNJARO (TIRZEPATIDE) INDICATION AND SAFETY SUMMARY WITH WARNINGS Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus

8 It is also responsible for determining how fat is metabolized in the liver and how it is stored in the body

doi: 10.1038/s41586-019-1705-2 8 BockF

Or at 5.0 mg/mL, a 1.25mg dose would be: (1.25 / 5.0) x 100 = 25 units

Documentation quality Use of batch-level documentation and traceability versus generic or reused Certificates of Analysis (COAs)

Diabetologia (2010) 53(1):1539